Schedule 13G ownership disclosure

Nexvet Biopharma plc

Security class unavailable · CUSIP: G6503X109

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
873,372
Percent of class
7.6200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-096935
Form type
SC 13G
Filer
BioScience Managers PTY LTD
CIK
CIK 1666567
Filed
Feb 16, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub